Emmecell
Emmetrope Ophthalmics LLC,(aka “Emmecell”) is a privately-held, clinical stage biotechnology company developing cell-based therapies. Emmecell’s platform technology leverages magnetic nanoparticles to effectively localize and integrate cell therapies to the appropriate target tissue. Our lead product EO2002 is a cell therapy for treatment for corneal edema, the most common indication for corneal transplantation. Cell Manufacturing and Production LLC (CellMP) was founded in 2018 and is a subsidiary of Emmecell providing GMP manufacturing services in Menlo Park, CA.
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
12
1 to 10 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 9 verified contacts at Emmecell
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
- CF
Christy Fleming
Director of Clinical Operations · Operations
EmailPhone - HE
Heather Elliott
Document Controller · Operations
EmailPhone - RB
Reza Bahranifard
Scientist · Research & Development
EmailPhone - TN
Thanh Nguyen
Qa Consultant Director · Other
EmailPhone
Showing 4 of 9 verified contacts
Top roles at Emmecell
6 distinct titles indexed · top 6 shown.
- 1board observer
- 1director of clinical operations
- 1document controller
- 1qa consultant director
- 1research associate
- 1scientist
Sign up to unlock all 9 contacts at Emmecell
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Emmecell
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.